Thyroid lobectomy (hemithyroidectomy) — when half is enough

A thyroid lobectomy, also called a hemithyroidectomy, is surgery to remove one of the two lobes of the thyroid gland, usually along with the small middle part called the isthmus. It is a form of partial thyroid removal — the other lobe is left in place. Because half the gland remains, it often keeps producing enough thyroid hormone on its own. The operation is done through a small cut in the lower neck while you are asleep under general anaesthetic. It is one of the two main thyroid operations, the other being total thyroidectomy, which removes the whole gland. A specialist decides which is right based on the type, size, and behaviour of the problem.

A thyroid lobectomy can be enough when the cancer is small, low-risk, and confined to one lobe. This is most often the case for small papillary thyroid cancers — for example tumours up to about 1 to 4 cm with no spread to lymph nodes and no other worrying features. In these situations, guidelines accept lobectomy as an alternative to removing the whole gland, with similar long-term outcomes. The aim is to do enough to treat the cancer safely while keeping as much healthy thyroid as possible. The exact threshold depends on the biopsy, the ultrasound, and the final pathology, so the decision is always made by a specialist team for your specific case.

A lobectomy removes half the thyroid — one lobe — and leaves the other half in place. A total thyroidectomy removes the entire gland. The main practical difference is what happens afterwards. After a lobectomy, the remaining lobe often makes enough hormone, so some people need no tablets at all, though many still need some. After a total thyroidectomy, the body makes no thyroid hormone, so daily hormone tablets are needed for life. Removing the whole gland is preferred for larger, higher-risk, or spreading cancers, and is needed if radioactive iodine treatment is planned. Half is enough only when the cancer is small and low-risk. A tumour board weighs these trade-offs for each person.

Not always, but often. Because half the thyroid is left in place after a hemithyroidectomy, the remaining lobe can sometimes make enough hormone on its own. However, roughly a quarter to a third of people still need thyroid hormone tablets afterwards, because the remaining lobe does not keep up. This is checked with a simple blood test a few weeks after surgery, and tablets are started if your levels are low. The dose is easy to adjust and is taken once a day. Your team will explain how your levels will be monitored, so any need for tablets is picked up early and managed simply.

Recovery from a thyroid lobectomy is usually quicker than from a total thyroidectomy. Many people stay in hospital for a day, sometimes overnight, and go home once they are eating, drinking, and comfortable. The neck may feel sore or stiff for a week or two, and the voice can feel tired at first. Most people return to light activity within a week and normal routine within two to three weeks. The scar is in a natural skin crease low on the neck and fades over months. Your team gives clear advice on wound care, when to resume work, and what follow-up to expect. Most recoveries are straightforward.

A thyroid lobectomy is a common, well-established operation with a good safety record when done by an experienced thyroid surgeon. As with any surgery there are risks, but they are uncommon. The main ones are temporary voice changes if the nerve to the voice box is irritated, and bleeding or infection at the wound. Because only one lobe is removed, the risk to the parathyroid glands that control calcium is lower than with total thyroidectomy. Serious complications are rare. The best way to lower risk is to have the surgery done by a high-volume specialist team that reviews each case carefully beforehand. Your surgeon will explain the specific risks for you.

Not effectively, while half the thyroid remains. Radioactive iodine works by being taken up by thyroid tissue, so it is normally given only after the whole gland has been removed. If the final pathology after a lobectomy shows higher-risk features, the team may recommend a second operation to remove the remaining lobe — called a completion thyroidectomy — so that radioactive iodine can then be used if needed. This is one reason lobectomy is chosen mainly for small, low-risk cancers where radioactive iodine is not expected to be required. The pathology of the removed lobe guides whether any further step is needed.

Sometimes the lab examination of the removed lobe shows features that were not clear before surgery — for example a larger tumour, an aggressive subtype, or spread that was not seen on scans. If that happens, the tumour board reviews the findings and may recommend a completion thyroidectomy to remove the remaining lobe, or other treatment such as radioactive iodine. This is part of normal, careful care, not a sign that anything went wrong. Planning for this possibility in advance is exactly why a specialist team and a clear follow-up plan matter. You deserve to understand each step, so any further treatment is explained fully before it is decided.

Yes, and it is a reasonable thing to ask for. The choice between a lobectomy and removing the whole thyroid affects whether you need lifelong tablets and what follow-up looks like, so it is worth getting right. A specialist review can confirm the type and size, check the ultrasound and biopsy, and explain why half may or may not be enough for you. A free, written second opinion can give you confidence in the plan before any operation. At CION, a doctor-led tumour board reviews each case together, with a 45-minute consultation and transparent costs, so the decision is made for healing, not billing.